SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunex
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
656 41 0 IMNX
Emcee:  Michael Yang Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
106 Roche apparently discontinued testing in clinical stage II of their arthritis Deryck Jordan-10/9/1997
105 I saw that soloman upgraded it, but the week before someone upgraded it to buy brian marks-10/8/1997
104 Immunex is looking at a profitable 3rd quarter, not to mention good data on Enbtargetedmoab-10/8/1997
103 Well, we aren't seen nothing yet. (See message #90) Samshdu-10/8/1997
102 big jump! Soloman instituted coverage of imnx with a 12 month target of $84. Pamike head-10/8/1997
101 Howdy AJAG... Maybe the Forbes article which hit the stands today, I think. jJoel Oseran-10/8/1997
100 Why is this thread so dead when the stock goes up like it did today?Brendan2012-10/8/1997
99 Does anyone know why the stock went up eight bucks on no news today?AJAG-10/8/1997
98 Where is everybody?Howard Henick-10/8/1997
97 Hey where is Greg now that Immunex is up 4 fold and Xoma has doubled? DLJ calliHoward Henick-9/27/1997
96 Don, IMNX 66 1/8 + 6 3/8 Never say never. Regards, The Thrifty InvestorThe Thrifty Investor-9/26/1997
95 It could never be wrong to take profit when the stock jumps 20 points in the laDon Cheng-9/15/1997
94 I did mean to say that I did not think Immunex would risk the negative publiThe Thrifty Investor-9/14/1997
93 More comments: >>I think that $7,000 per year is too high. Yes, some peoshdu-9/14/1997
92 Sam, I tend to agree that $600 per year would be a generously low price forThe Thrifty Investor-9/13/1997
91 I believe it was someone at Merck who once called a sucessful RA therapy "I. Luttichuys-9/13/1997
90 some comments on the message by "The Thrifty Investor": >>Asthshdu-9/13/1997
89 Rich, I believe that your assumption of $100 per year for Enbrel is wrong. The Thrifty Investor-9/12/1997
88 Well I sold out today. It seems to me that the value was getting too high. I rerich evans-9/12/1997
87 Good call Howard. Thestreet ( thestreet.com ) has a nice article on IMNX todayHenry Niman-9/12/1997
86 OFF TOPIC.......Richard, have you checked out TelSave(TALK)lately? Id love to BamaReb-9/6/1997
85 I assume you mean that the stock price is 5 to 10 times what the company is reaRichard Ogier-8/31/1997
84 Howard, There must be something wrong with my calculation. My numbers tell me shdu-8/30/1997
83 Hit 45. Should make a run at 50 now.Howard Henick-8/30/1997
82 <<My understanding is Phase 3 trials are finished and the data is being cCharles Hill-8/21/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News